A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp. Mol. Med. 2007, 39, 756–768. [Google Scholar] [CrossRef] Sun, H.L.; Peng, M.L.; Lee, S.S.; Chen, C.J.; Chen, W....
A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp. Mol. Med. 2007, 39, 756–768. [Google Scholar] [CrossRef] Sun, H.L.; Peng, M.L.; Lee, S.S.; Chen, C.J.; Chen, W....